Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Peripheral Blood Stem Cell Transplantation"" wg kryterium: Temat


Tytuł :
Early autologous and allogeneic peripheral blood stem cell transplantation for adult patients with acute B and T cell precursor neoplasms: a 12-year single center experience.
Autorzy :
Steiner N; University Hospital of Internal Medicine V, Hematology and Medical Oncology, Innsbruck Medical University, Innsbruck, Austria. .
Brunelli L; University Hospital of Internal Medicine V, Hematology and Medical Oncology, Innsbruck Medical University, Innsbruck, Austria.
Hetzenauer G; University Hospital of Internal Medicine V, Hematology and Medical Oncology, Innsbruck Medical University, Innsbruck, Austria.
Lindner B; University Hospital of Internal Medicine V, Hematology and Medical Oncology, Innsbruck Medical University, Innsbruck, Austria.
Göbel G; Department of Medical Statistics, Informatics and Health Economics, Innsbruck Medical University, Innsbruck, Austria.
Rudzki J; University Hospital of Internal Medicine V, Hematology and Medical Oncology, Innsbruck Medical University, Innsbruck, Austria.
Peschel I; Central Institute for Medical and Chemical Laboratory Diagnostics, Innsbruck Medical University, Innsbruck, Austria.
Nevinny-Stickel M; Department of Radiooncology, Innsbruck Medical University, Innsbruck, Austria.
Nussbaumer W; Central Institute for Blood Transfusion and Immunology, Medical University Hospital Innsbruck, Innsbruck, Austria.
Mayer W; Central Institute for Blood Transfusion and Immunology, Medical University Hospital Innsbruck, Innsbruck, Austria.
Loacker L; Central Institute for Medical and Chemical Laboratory Diagnostics, Innsbruck Medical University, Innsbruck, Austria.
Kircher B; University Hospital of Internal Medicine V, Hematology and Medical Oncology, Innsbruck Medical University, Innsbruck, Austria.
Gunsilius E; University Hospital of Internal Medicine V, Hematology and Medical Oncology, Innsbruck Medical University, Innsbruck, Austria.
Wolf D; University Hospital of Internal Medicine V, Hematology and Medical Oncology, Innsbruck Medical University, Innsbruck, Austria.
Nachbaur D; University Hospital of Internal Medicine V, Hematology and Medical Oncology, Innsbruck Medical University, Innsbruck, Austria.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Mar; Vol. 100 (3), pp. 809-816. Date of Electronic Publication: 2021 Jan 26.
Typ publikacji :
Journal Article
MeSH Terms :
Early Medical Intervention*/methods
Peripheral Blood Stem Cell Transplantation/*methods
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Adolescent ; Adult ; Aged ; Austria/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Neoplasm, Residual ; Peripheral Blood Stem Cell Transplantation/adverse effects ; Peripheral Blood Stem Cell Transplantation/statistics & numerical data ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/epidemiology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Recurrence ; Remission Induction ; Retrospective Studies ; Time Factors ; Time-to-Treatment ; Transplantation, Autologous ; Transplantation, Homologous ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Hepatitis B Virus Reactivation 55 Months Following Chemotherapy Including Rituximab and Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma.
Autorzy :
Hara T; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Oka K; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Iwai N; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Inada Y; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Tsuji T; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Okuda T; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Nagata A; Department of Pathology, Fukuchiyama City Hospital, Japan.
Komaki T; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Kagawa K; Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2021 Feb 01; Vol. 60 (3), pp. 417-421. Date of Electronic Publication: 2020 Sep 19.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Hepatitis B*
Peripheral Blood Stem Cell Transplantation*/adverse effects
Female ; Hepatitis B Surface Antigens ; Hepatitis B virus ; Humans ; Male ; Middle Aged ; Rituximab/adverse effects ; Virus Activation
Czasopismo naukowe
Tytuł :
Comparison of myeloablative and reduced intensity conditioning unrelated donor allogeneic peripheral blood stem cell transplant outcomes for AML using thymoglobulin for GVHD prophylaxis.
Autorzy :
Modi D; Department of Oncology, Karmanos Cancer Institute/Wayne State University, 4100 John R, HW04H0, Detroit, MI, 48201, USA. .
Singh V; Department of Oncology, Karmanos Cancer Institute/Wayne State University, 4100 John R, HW04H0, Detroit, MI, 48201, USA.
Kim S; Biostatistics Core, Karmanos Cancer Institute, Department of Oncology, Wayne State University, Detroit, MI, 48201, USA.
Ayash L; Department of Oncology, Karmanos Cancer Institute/Wayne State University, 4100 John R, HW04H0, Detroit, MI, 48201, USA.
Deol A; Department of Oncology, Karmanos Cancer Institute/Wayne State University, 4100 John R, HW04H0, Detroit, MI, 48201, USA.
Ratanatharathorn V; Department of Oncology, Karmanos Cancer Institute/Wayne State University, 4100 John R, HW04H0, Detroit, MI, 48201, USA.
Uberti JP; Department of Oncology, Karmanos Cancer Institute/Wayne State University, 4100 John R, HW04H0, Detroit, MI, 48201, USA.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 969-978. Date of Electronic Publication: 2021 Feb 16.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Peripheral Blood Stem Cell Transplantation*
Antilymphocyte Serum/*therapeutic use
Busulfan/*therapeutic use
Graft vs Host Disease/*prevention & control
Immunosuppressive Agents/*therapeutic use
Leukemia, Myeloid, Acute/*therapy
Myeloablative Agonists/*therapeutic use
Transplantation Conditioning/*methods
Vidarabine/*analogs & derivatives
Aged ; Allografts ; Busulfan/adverse effects ; Female ; Graft vs Host Disease/etiology ; Humans ; Infections/epidemiology ; Lymphocyte Depletion ; Male ; Middle Aged ; Mycophenolic Acid/therapeutic use ; Myeloablative Agonists/adverse effects ; Progression-Free Survival ; Retrospective Studies ; T-Lymphocytes ; Tacrolimus/therapeutic use ; Treatment Outcome ; Unrelated Donors ; Vidarabine/adverse effects ; Vidarabine/therapeutic use ; Whole-Body Irradiation
Czasopismo naukowe
Tytuł :
Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation.
Autorzy :
Bailén R; Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain. .; Gregorio Marañón Health Research Institute, Madrid, Spain. .
Kwon M; Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute, Madrid, Spain.
Pascual-Cascón MJ; Department of Hematology and Hemotherapy, Hospital Regional Universitario de Málaga, Málaga, Spain.
Ferrà C; Department of Hematology and Hemotherapy, Institut Català d'Oncologia Badalona, Barcelona, Spain.
Sanz J; Department of Hematology and Hemotherapy, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Gallardo-Morillo A; Department of Hematology and Hemotherapy, Hospital Regional Universitario de Málaga, Málaga, Spain.
García-Sola A; Department of Hematology and Hemotherapy, Hospital Regional Universitario de Málaga, Málaga, Spain.
Torrent A; Department of Hematology and Hemotherapy, Institut Català d'Oncologia Badalona, Barcelona, Spain.
Jiménez-Lorenzo MJ; Department of Hematology and Hemotherapy, Institut Català d'Oncologia Badalona, Barcelona, Spain.
Piñana JL; Department of Hematology and Hemotherapy, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Montoro J; Department of Hematology and Hemotherapy, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Oarbeascoa G; Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute, Madrid, Spain.
Dorado N; Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute, Madrid, Spain.
Gómez-Centurión I; Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Muñoz C; Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Martínez-Laperche C; Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute, Madrid, Spain.
Anguita J; Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute, Madrid, Spain.; Universidad Complutense de Madrid, Madrid, Spain.
Buño I; Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute, Madrid, Spain.
Díez-Martín JL; Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute, Madrid, Spain.; Universidad Complutense de Madrid, Madrid, Spain.
Pokaż więcej
Corporate Authors :
Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH)
Źródło :
Annals of hematology [Ann Hematol] 2021 Feb; Vol. 100 (2), pp. 541-553. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article; Multicenter Study
MeSH Terms :
Graft vs Host Disease*/mortality
Graft vs Host Disease*/prevention & control
Peripheral Blood Stem Cell Transplantation*
Unrelated Donors*
Antilymphocyte Serum/*administration & dosage
Cyclophosphamide/*administration & dosage
Adolescent ; Adult ; Aged ; Allografts ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Middle Aged ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia.
Autorzy :
Nagler A; Division of Hematology, Chaim Sheba Medical Center, Tel Aviv University, Tel Hashomer, Israel.; EBMT ALWP Office, Saint Antoine Hospital, Paris, France.
Dholaria B; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. .
Labopin M; Department of Haematology and EBMT Paris Study Office/CEREST-TC, Saint Antoine Hospital, Paris, France.
Savani BN; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
Angelucci E; Hematology and Transplant Center, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Koc Y; Medicana International, Istanbul, Turkey.
Arat M; Hematopoietic SCT Unit, Florence Nightingale Sisli Hospital, Istanbul, Turkey.
Pioltelli P; Ospedale San Gerardo, Clinica Ematologica dell'Universita Milano-Biocca, Monza, Italy.
Sica S; Divisione di Ematologia, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy.
Gülbas Z; Bone Marrow Transplantation Department, Anadolu Medical Center Hospital, Kocaeli, Turkey.
Tischer J; Klinikum Grosshadern, Med. Klinik III, Munich, Germany.
Bernasconi P; BMT Unit, Clinica Ematologica, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Pavlu J; Department of Haematology, Hammersmith Hospital, Imperial College, London, UK.
Socié G; Dept. of Hematology-BMT, Hospital St. Louis, Paris, France.
Blaise D; Programme de Transplantation&Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
Rigacci L; Dept. of Hematology and BMT, Ospedale S. Camillo-Forlanini, Rome, Italy.
Martino M; Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Centro Unico Trapianti A. Neri, Alberto Neri, Bianchi-Melacrino-Morelli, Reggio Calabri, Italy.
Diez-Martin JL; Department of Hematology, Hospital GU Gregorio Marañon, Instituto de Investigación Sanitaria Gregorio Marañon' Universidad Complutense Medicina, Madrid, Spain.
Perić Z; Dept.of Internal Medicine, University of Zagreb, School of Medicine, Zagreb, Croatia.
Giebel S; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Institute-Oncology Center, Gliwice Branch, Gliwice, Poland.
Mohty M; EBMT ALWP Office, Saint Antoine Hospital, Paris, France.; Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, AP-HP, Sorbonne University, and INSERM UMRs 938, Paris, France.
Pokaż więcej
Źródło :
Leukemia [Leukemia] 2020 Oct; Vol. 34 (10), pp. 2766-2775. Date of Electronic Publication: 2020 May 11.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Bone Marrow Transplantation*/adverse effects
Bone Marrow Transplantation*/methods
Hematopoietic Stem Cell Mobilization*
Lymphocyte Depletion*
Peripheral Blood Stem Cell Transplantation*/adverse effects
Peripheral Blood Stem Cell Transplantation*/methods
Transplantation, Haploidentical*
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Cause of Death ; Combined Modality Therapy ; Female ; Graft vs Host Disease/diagnosis ; Graft vs Host Disease/etiology ; Humans ; Male ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Proportional Hazards Models ; T-Lymphocytes ; Transplantation Conditioning/methods ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies.
Autorzy :
Gao XN; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Lin J; Institute of Basic Medicine, Graduate School, Chinese PLA General Hospital, Beijing, 100853, China.
Wang LJ; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Li F; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Li HH; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Wang SH; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Huang WR; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Gao CJ; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Yu L; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Liu DH; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2020 Aug; Vol. 99 (8), pp. 1883-1893. Date of Electronic Publication: 2020 Jun 22.
Typ publikacji :
Journal Article
MeSH Terms :
Hematologic Neoplasms*/mortality
Hematologic Neoplasms*/therapy
Hematologic Neoplasms*/virology
Peripheral Blood Stem Cell Transplantation*
Siblings*
Virus Activation*
Cytomegalovirus/*physiology
Cytomegalovirus Infections/*mortality
Adolescent ; Adult ; Allografts ; Child ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Survival Rate
Czasopismo naukowe
Tytuł :
Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML.
Autorzy :
Jentzsch M; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Liebigstraße 22, Haus 7, 04103, Leipzig, Germany.
Bill M; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Liebigstraße 22, Haus 7, 04103, Leipzig, Germany.
Grimm J; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Liebigstraße 22, Haus 7, 04103, Leipzig, Germany.
Brauer D; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Liebigstraße 22, Haus 7, 04103, Leipzig, Germany.
Backhaus D; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Liebigstraße 22, Haus 7, 04103, Leipzig, Germany.
Goldmann K; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Liebigstraße 22, Haus 7, 04103, Leipzig, Germany.
Schulz J; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Liebigstraße 22, Haus 7, 04103, Leipzig, Germany.
Niederwieser D; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Liebigstraße 22, Haus 7, 04103, Leipzig, Germany.
Platzbecker U; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Liebigstraße 22, Haus 7, 04103, Leipzig, Germany.
Schwind S; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Liebigstraße 22, Haus 7, 04103, Leipzig, Germany. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2020 Oct; Vol. 99 (10), pp. 2417-2427. Date of Electronic Publication: 2020 Aug 29.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Peripheral Blood Stem Cell Transplantation*
Bone Marrow/*pathology
Leukemia, Myeloid, Acute/*therapy
Neoplasm Proteins/*genetics
Trans-Activators/*genetics
Tumor Suppressor Proteins/*genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Allografts ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bone Marrow/chemistry ; Combined Modality Therapy ; Cytarabine/administration & dosage ; Disease-Free Survival ; Female ; Gene Dosage ; Gene Expression Regulation, Neoplastic ; Humans ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/mortality ; Male ; Middle Aged ; Neoplasm Proteins/biosynthesis ; Polymerase Chain Reaction/methods ; Prognosis ; Proto-Oncogene Proteins c-abl/genetics ; Trans-Activators/biosynthesis ; Treatment Outcome ; Tumor Suppressor Proteins/biosynthesis ; Young Adult
Czasopismo naukowe
Tytuł :
Unintentional human leukocyte antigen-mismatched haematopoietic cell transplant: clinical course and root cause analysis.
Autorzy :
Bo A; Hematology and Transplant Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Raiola AM; Hematology and Transplant Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Gualandi F; Hematology and Transplant Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Orengo G; Quality and risk management, accreditation and pr, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Dapino P; Quality and risk management, accreditation and pr, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Gianelli Castiglione A; Legal medicine, IRCCS Ospedale Policlinico San Martino, Genova, Coordinamento Trapianti Regione Liguria, Genova, Italy.
Angelucci E; Hematology and Transplant Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2020 Oct; Vol. 191 (1), pp. e35-e37. Date of Electronic Publication: 2020 Jul 21.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
HLA Antigens*
Medical Errors*
Peripheral Blood Stem Cell Transplantation*
Transplantation Conditioning*
Leukemia, Myeloid, Acute/*therapy
Allografts ; Humans ; Leukemia, Myeloid, Acute/blood ; Male ; Middle Aged
Raport
Tytuł :
Graft-versus-host disease of the kidney.
Autorzy :
Koratala A; Division of Nephrology, Hypertension and Renal Transplantation, University of Florida, Gainesville, FL, USA. Electronic address: .
Segal MS; Division of Nephrology, Hypertension and Renal Transplantation, University of Florida, Gainesville, FL, USA.
Farhadfar N; Division of Hematology and Oncology, University of Florida, Gainesville, FL, USA.
Zeng X; Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA.
Pokaż więcej
Źródło :
Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2020 Sep; Vol. 13 (3), pp. 178-179. Date of Electronic Publication: 2019 Feb 20.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Diabetes Mellitus, Type 2*/metabolism
Diabetes Mellitus, Type 2*/pathology
Diabetes Mellitus, Type 2*/therapy
Graft vs Host Disease*/etiology
Graft vs Host Disease*/metabolism
Graft vs Host Disease*/pathology
Graft vs Host Disease*/therapy
Peripheral Blood Stem Cell Transplantation*
Polycythemia Vera*/metabolism
Polycythemia Vera*/pathology
Polycythemia Vera*/therapy
Renal Insufficiency, Chronic*/etiology
Renal Insufficiency, Chronic*/metabolism
Renal Insufficiency, Chronic*/pathology
Renal Insufficiency, Chronic*/therapy
Allografts ; Female ; Humans ; Middle Aged
Czasopismo naukowe
Tytuł :
Negative Impact of Borderline Creatinine Concentration and Glomerular Filtration Rate at Baseline on the Outcome of Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplant.
Autorzy :
Waszczuk-Gajda A; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland. Electronic address: .
Małyszko J; Department of Nephrology, Dialysistherapy and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.
Vesole DH; Myeloma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey, United States.
Feliksbrot-Bratosiewicz M; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Skwierawska K; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Krzanowska K; Department of Nephrology, Jagiellonian University Medical College, Kraków, Poland.
Kobylińska K; University of Warsaw, Faculty of Mathematics, Informatics and Mechanics, Warsaw, Poland.
Biecek P; University of Warsaw, Faculty of Mathematics, Informatics and Mechanics, Warsaw, Poland.
Snarski E; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Rodziewicz-Lurzyńska A; Central Laboratory, Clinical Center of Warsaw Medical University, Warsaw, Poland.
Kozłowski P; Central Laboratory, Clinical Center of Warsaw Medical University, Warsaw, Poland.
Stefaniak A; Cytogenetics Laboratory, Public Pediatric Teaching Hospital in Warsaw, Warsaw, Poland.
Drozd-Sokołowska J; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Ziarkiewicz M; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Vyas P; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Boguradzki P; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Mądry K; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Biliński J; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Tomaszewska A; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Maciejewska M; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Urbanowska E; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Blajer B; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Król M; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Król M; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Zborowska H; Department of Hematology, Jagiellonian University, Kraków, Poland.
Jurczyszyn A; Department of Hematology, Jagiellonian University, Kraków, Poland.
Dwilewicz-Trojaczek J; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Jedrzejczak WW; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Basak GW; Department of Hematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland.
Pokaż więcej
Źródło :
Transplantation proceedings [Transplant Proc] 2020 Sep; Vol. 52 (7), pp. 2186-2192. Date of Electronic Publication: 2020 Mar 26.
Typ publikacji :
Journal Article
MeSH Terms :
Multiple Myeloma/*complications
Multiple Myeloma/*therapy
Peripheral Blood Stem Cell Transplantation/*methods
Renal Insufficiency/*diagnosis
Renal Insufficiency/*etiology
Adult ; Aged ; Creatinine/blood ; Female ; Glomerular Filtration Rate ; Humans ; Male ; Middle Aged ; Peripheral Blood Stem Cell Transplantation/mortality ; Renal Insufficiency/classification ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
[Influencing Factors and Prevation of Infection in Leukemia Patients after Allogeneic Peripheral Blood Stem Cell Transplantation].
Autorzy :
Shen YQ; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
Fu YY; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
Li LM; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China,E-mail: .
Wang Y; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
Meng LL; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
Zhai QY; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
Pokaż więcej
Źródło :
Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2020 Aug; Vol. 28 (4), pp. 1344-1348.
Typ publikacji :
Journal Article
MeSH Terms :
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Infections*
Leukemia*
Peripheral Blood Stem Cell Transplantation*
Humans
Czasopismo naukowe
Tytuł :
[Peripheral blood stem cell transplantation from HLA-mismatched unrelated donor or haploidentical donor for the treatment of X-linked agammaglobulinemia].
Autorzy :
Nie L; Department of Hematology, Xiangya Hospital, Central South University, Changsha 410008, China. .
Su T
Yang KT
Zhao L
Hu J
Yang SH
Xu YJ
Fu B
Pokaż więcej
Źródło :
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics [Zhongguo Dang Dai Er Ke Za Zhi] 2020 Aug; Vol. 22 (8), pp. 821-827.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Graft vs Host Disease*
Peripheral Blood Stem Cell Transplantation*
Agammaglobulinemia/*therapy
Genetic Diseases, X-Linked/*therapy
HLA Antigens ; Hematopoietic Stem Cell Transplantation ; Humans ; Treatment Outcome ; Unrelated Donors ; Young Adult
SCR Disease Name :
Bruton type agammaglobulinemia
Czasopismo naukowe
Tytuł :
Allogeneic Peripheral Blood Stem Cell Transplant: Correlation of Donor Factors with Yield, Engraftment, Chimerism, and Outcome: Retrospective Review of a Single Institute During a 3-Year Period.
Autorzy :
Philip J; Department of Immunohematology & Blood Transfusion (IH & BT), Armed Forces Medical College (AFMC), Pune, India.
Bajaj AK; Department of Immunohematology & Blood Transfusion (IH & BT), Armed Forces Medical College (AFMC), Pune, India.
Sharma S; Department of Hematology, Command Hospital, Pune, India.
Kushwaha N; Department of Immunohematology & Blood Transfusion (IH & BT), Armed Forces Medical College (AFMC), Pune, India.
Kumar S; Department of Immunohematology & Blood Transfusion (IH & BT), Armed Forces Medical College (AFMC), Pune, India.
Kumar Biswas A; Department of Immunohematology & Blood Transfusion (IH & BT), Armed Forces Medical College (AFMC), Pune, India.
Pokaż więcej
Źródło :
Laboratory medicine [Lab Med] 2020 Jul 08; Vol. 51 (4), pp. 362-369.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors/*statistics & numerical data
Graft vs Host Disease/*epidemiology
Peripheral Blood Stem Cell Transplantation/*adverse effects
Age Factors ; Antigens, CD34/genetics ; Antigens, CD34/metabolism ; Filgrastim/pharmacology ; Granulocyte Colony-Stimulating Factor/metabolism ; Hematologic Agents/pharmacology ; Humans ; Peripheral Blood Stem Cell Transplantation/methods ; Peripheral Blood Stem Cell Transplantation/statistics & numerical data ; Peripheral Blood Stem Cells/drug effects ; Peripheral Blood Stem Cells/metabolism ; Transplantation, Homologous
Czasopismo naukowe
Tytuł :
Pre-infusion single-dose mesenchymal stem cells promote platelet engraftment and decrease severe acute graft versus host disease without relapse in haploidentical peripheral blood stem cell transplantation.
Autorzy :
Wang X; Department of Hematology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zhang M; Department of Hematology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
He P; Department of Hematology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Pokaż więcej
Źródło :
The Journal of international medical research [J Int Med Res] 2020 May; Vol. 48 (5), pp. 300060520920438.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
MeSH Terms :
Graft vs Host Disease/*prevention & control
Leukemia/*therapy
Mesenchymal Stem Cell Transplantation/*methods
Myelodysplastic Syndromes/*therapy
Peripheral Blood Stem Cell Transplantation/*adverse effects
Secondary Prevention/*methods
Transplantation Conditioning/*methods
Adolescent ; Adult ; Child ; Female ; Graft vs Host Disease/blood ; Graft vs Host Disease/diagnosis ; Graft vs Host Disease/etiology ; Humans ; Male ; Middle Aged ; Peripheral Blood Stem Cell Transplantation/methods ; Platelet Count ; Platelet Transfusion/statistics & numerical data ; Recurrence ; Severity of Illness Index ; Transplantation, Haploidentical/adverse effects ; Transplantation, Haploidentical/methods ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Safe administration of granulocyte colony-stimulating factor (G-CSF) to a patient with G-CSF-producing multiple myeloma.
Autorzy :
Kikuchi T; Department of Medicine, Division of Hematology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. .
Kato J; Department of Medicine, Division of Hematology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Koda Y; Department of Medicine, Division of Hematology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Sakurai M; Department of Medicine, Division of Hematology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Hayashi Y; Department of Diagnostic Pathology, Keio University Hospital, Tokyo, Japan.
Mori T; Department of Medicine, Division of Hematology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2020 Jul; Vol. 99 (7), pp. 1667-1668. Date of Electronic Publication: 2020 Jun 06.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Granulocyte Colony-Stimulating Factor*/administration & dosage
Granulocyte Colony-Stimulating Factor*/biosynthesis
Hematopoietic Stem Cell Mobilization*
Multiple Myeloma*/metabolism
Multiple Myeloma*/pathology
Multiple Myeloma*/therapy
Neoplasm Proteins*/administration & dosage
Neoplasm Proteins*/biosynthesis
Peripheral Blood Stem Cell Transplantation*
Aged ; Autografts ; Female ; Humans
Raport
Tytuł :
A retrospective analysis of treatment outcomes in 45 patients with cardiac light-chain amyloidosis: a single-center experience in Japan.
Autorzy :
Fuchida SI; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, 27 Shimofusa-cho, Kita-ku, Kyoto, 603-8151, Japan. .
Ide D; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, 27 Shimofusa-cho, Kita-ku, Kyoto, 603-8151, Japan.
Taminishi-Katsuragawa Y; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, 27 Shimofusa-cho, Kita-ku, Kyoto, 603-8151, Japan.
Suga T; Department of Cardiology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
Matsui-Maegawa S; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, 27 Shimofusa-cho, Kita-ku, Kyoto, 603-8151, Japan.
Maruyama N; Department of Cardiology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
Iwamura Y; Department of Cardiology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
Kitamura Y; Department of Cardiology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
Okawa Y; Department of Cardiology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
Okano A; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, 27 Shimofusa-cho, Kita-ku, Kyoto, 603-8151, Japan.; Department of Hematology, Omihachiman Community Medical Center, Omihachiman, Japan.
Hatsuse M; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, 27 Shimofusa-cho, Kita-ku, Kyoto, 603-8151, Japan.
Murakami S; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, 27 Shimofusa-cho, Kita-ku, Kyoto, 603-8151, Japan.
Shimazaki C; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, 27 Shimofusa-cho, Kita-ku, Kyoto, 603-8151, Japan.
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2020 Jun; Vol. 111 (6), pp. 803-811. Date of Electronic Publication: 2020 Feb 04.
Typ publikacji :
Journal Article
MeSH Terms :
Peripheral Blood Stem Cell Transplantation*
Bortezomib/*administration & dosage
Cardiomyopathies/*therapy
Cyclophosphamide/*administration & dosage
Dexamethasone/*administration & dosage
Immunoglobulin Light-chain Amyloidosis/*therapy
Melphalan/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Biomarkers/blood ; Cardiomyopathies/diagnosis ; Cardiomyopathies/mortality ; Drug Therapy, Combination ; Female ; Humans ; Immunoglobulin Light-chain Amyloidosis/diagnosis ; Immunoglobulin Light-chain Amyloidosis/mortality ; Japan ; Male ; Middle Aged ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood ; Prognosis ; Retrospective Studies ; Retroviridae Proteins, Oncogenic ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
[Long term remission after syngeneic peripheral blood hematopoietic stem cell transplantation without conditioning regimen in a patient with severe aplastic anemia].
Autorzy :
Ma FY; Department of Hematology, the First Affiliated Hospital of China Medical University, Shenyang 110001, China; Department of Nephrology, Taikang Xianlin Drum Tower Hospital, Nanjing 210000, China.
Feng HM; Department of Hematology, the First Affiliated Hospital of China Medical University, Shenyang 110001, China.
Gao F; Department of Hematology, the First Affiliated Hospital of China Medical University, Shenyang 110001, China.
He J; Department of Hematology, the First Affiliated Hospital of China Medical University, Shenyang 110001, China.
Li Y; Department of Hematology, the First Affiliated Hospital of China Medical University, Shenyang 110001, China.
Cai DL; Department of Hematology, the First Affiliated Hospital of China Medical University, Shenyang 110001, China.
Pokaż więcej
Źródło :
Zhonghua nei ke za zhi [Zhonghua Nei Ke Za Zhi] 2020 Jun 01; Vol. 59 (6), pp. 467-469.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Peripheral Blood Stem Cell Transplantation*
Anemia, Aplastic/*surgery
Anemia, Aplastic/pathology ; Graft vs Host Disease ; Humans ; Transplantation Conditioning ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Comparative study of micro-transplantation from HLA fully mismatched unrelated and partly matched related donors in acute myeloid leukemia.
Autorzy :
Hu KX; Department of Hematology and Transplantation, Fifth Medical Center, General Hospital of the Chinese People's Liberation Army, Beijing, China.
Du X; Department of Hematology, Guangdong People's Hospital, Gongdong, China.
Guo M; Department of Hematology and Transplantation, Fifth Medical Center, General Hospital of the Chinese People's Liberation Army, Beijing, China.
Yu CL; Department of Hematology and Transplantation, Fifth Medical Center, General Hospital of the Chinese People's Liberation Army, Beijing, China.
Qiao JH; Department of Hematology and Transplantation, Fifth Medical Center, General Hospital of the Chinese People's Liberation Army, Beijing, China.
Sun QY; Department of Hematology and Transplantation, Fifth Medical Center, General Hospital of the Chinese People's Liberation Army, Beijing, China.
Zuo HL; Department of Hematology and Transplantation, Fifth Medical Center, General Hospital of the Chinese People's Liberation Army, Beijing, China.
Cai B; Department of Hematology and Transplantation, Fifth Medical Center, General Hospital of the Chinese People's Liberation Army, Beijing, China.
Huang YJ; Department of Hematology and Transplantation, Fifth Medical Center, General Hospital of the Chinese People's Liberation Army, Beijing, China.
Ai HS; Department of Hematology and Transplantation, Fifth Medical Center, General Hospital of the Chinese People's Liberation Army, Beijing, China.
Dong Z; Department of Hematology and Transplantation, Fifth Medical Center, General Hospital of the Chinese People's Liberation Army, Beijing, China.
Wang Y; Department of Hematology and Transplantation, Fifth Medical Center, General Hospital of the Chinese People's Liberation Army, Beijing, China.
Pokaż więcej
Źródło :
American journal of hematology [Am J Hematol] 2020 Jun; Vol. 95 (6), pp. 630-636. Date of Electronic Publication: 2020 Apr 03.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Leukemia, Myeloid, Acute*/mortality
Leukemia, Myeloid, Acute*/therapy
Peripheral Blood Stem Cell Transplantation*
Unrelated Donors*
Adolescent ; Adult ; Aged ; Allografts ; Disease-Free Survival ; Female ; HLA Antigens ; Humans ; Male ; Middle Aged ; Survival Rate
Czasopismo naukowe
Tytuł :
Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission.
Autorzy :
Díaz-Beyá M; Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; IDIBAPS, Josep Carreras Leukemia Research Institute, Barcelona, Spain.
Labopin M; EBMT Paris Study Office, Department of Hematology and Cell Therapy, Hôpital Saint-Antoine, Paris, France.
Maertens J; University Hospital Gasthuisberg, Leuven, Belgium.
Aljurf M; King Faisal Specialist Hospital & Research Centre Oncology, Riyadh, Saudi Arabia.
Passweg J; University Hospital Hematology, Basel, Switzerland.
Dietrich B; Department of Bone Marrow Transplantation, University Hospital, Essen, Germany.
Schouten H; Department of Internal Medicine, Hematology/Oncology, University Hospital, Maastricht, The Netherlands.
Socié G; Division of Hematology, Hospital Saint Louis & University Paris, Paris, France.
Schaap N; Radbud University Medical Centre, Nijmegen, The Netherlands.
Schwerdtfeger R; Center for Hematopoietic Cell Transplantation, Deutsche Klinik für Diagnostik Helios Klinik, Wiesbaden, Germany.
Volin L; Stem Cell Transplantation Unit, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
Michallet M; Hôpital Edouard Herriot, Lyon, France.
Polge E; EBMT Paris Study Office, Department of Hematology and Cell Therapy, Hôpital Saint-Antoine, Paris, France.
Sierra J; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Santpau and Josep Carreras Leukemia Research Institute, Autonomous University of Barcelona, Barcelona, Spain.
Mohty M; EBMT Paris Study Office, Department of Hematology and Cell Therapy, Hôpital Saint-Antoine, Paris, France.; Department of Hematology, Hospital Saint Antoine, Paris, France.
Esteve J; Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; IDIBAPS, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.
Nagler A; EBMT Paris Study Office, Department of Hematology and Cell Therapy, Hôpital Saint-Antoine, Paris, France.; Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Pokaż więcej
Corporate Authors :
Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Źródło :
British journal of haematology [Br J Haematol] 2020 Jun; Vol. 189 (5), pp. 920-925. Date of Electronic Publication: 2020 Feb 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cord Blood Stem Cell Transplantation*
Peripheral Blood Stem Cell Transplantation*
Translocation, Genetic*
Chromosomal Proteins, Non-Histone/*genetics
Chromosomes, Human, Pair 6/*genetics
Chromosomes, Human, Pair 9/*genetics
Leukemia, Myeloid, Acute/*therapy
Nuclear Pore Complex Proteins/*genetics
Oncogene Proteins/*genetics
Oncogene Proteins, Fusion/*genetics
Poly-ADP-Ribose Binding Proteins/*genetics
Adult ; Allografts ; Chromosomes, Human, Pair 6/ultrastructure ; Chromosomes, Human, Pair 9/ultrastructure ; Disease-Free Survival ; Female ; Gene Duplication ; Graft vs Host Disease/etiology ; Humans ; Kaplan-Meier Estimate ; Leukemia, Myeloid, Acute/genetics ; Male ; Middle Aged ; Proportional Hazards Models ; Remission Induction ; Treatment Outcome ; fms-Like Tyrosine Kinase 3/genetics
Czasopismo naukowe
Tytuł :
Efficacy of VRD(Bortezomib, Lenalidomide, and Dexamethasone) Consolidation Therapy and Maintenance Therapy with Immunomodulatory Drugs(Thalidomide or Lenalidomide) after Autologous Peripheral Blood Stem Cell Transplantation in the Era of Bortezomib-Containing Induction Therapy-A Single Institution Experience.
Autorzy :
Tanimura A; Dept. of Hematology, Tokyo-Kita Medical Center.
Hirai R
Nakamura M
Takeshita M
Togano T
Sekine R
Hagiwara S
Miwa A
Pokaż więcej
Źródło :
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2020 May; Vol. 47 (5), pp. 789-796.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Multiple Myeloma*/therapy
Peripheral Blood Stem Cell Transplantation*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Bortezomib ; Consolidation Chemotherapy ; Dexamethasone ; Disease-Free Survival ; Humans ; Lenalidomide ; Retrospective Studies ; Thalidomide ; Transplantation, Autologous
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies